Back
Open Access

The CV polypill strategy (acetyl salicylic acid + atorvastatin + ramipril) as baseline treatment after a cardiovascular event supported by recent compelling evidence: a global expert consensus

Session: Poster session 1 - Managing cardiovascular risk: pharmacological and digital tools
Topic: Secondary Prevention
Speaker: Professor A. Abreu (Lisbon, PT)
Event: ESC Preventive Cardiology 2024

Congress Presentation

About the speaker

Professor Ana Abreu

Hospital de Santa Maria Faculty of Medicine, Lisbon (Portugal)
25 presentations
7 followers

5 more presentations in this session

Discussants - Managing cardiovascular risk: pharmacological and digital tools

Access
Thumbnail

Effect of statins on thoracic aortic disease: results from a meta-analysis and experimental data

Speaker: Doctor P. Poggio (Milan, IT)

Access
Abstract
Slides
Thumbnail

Accuracy of nine artificial intelligence chatbots in replying in accordance with the 2023 ESH guidelines for the management of arterial hypertension

Speaker: Mr D. Tsounis (Nea Makri, GR)

Access
Abstract
Thumbnail

Percentage and main features of patients referred to a cardiac rehabilitation program who would have an indication for a GLP1 receptor agonist based on the SELECT trial criteria

Speaker: Doctor J. Torres Marques (Palma de Mallorca, ES)

Access
Abstract
Slides
Thumbnail

Effect of SGLT2 inhibitors in the management of moroccan patients with heart failure with reduced ejection fraction

Speaker: Professor N. Mouine (Rabat, MA)

Access
Abstract
Slides
Thumbnail

Access the full session

Poster session 1 - Managing cardiovascular risk: pharmacological and digital tools

Speakers: Professor A. Abreu, Doctor P. Poggio, Mr D. Tsounis, Doctor J. Torres Marques, Professor N. Mouine
Access
Thumbnail

About the event

Image

ESC Preventive Cardiology 2024

25 April - 27 April 2024

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb